Clinical trial
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
NCT02851849
Study timeline
Study start (unknown)2016-09-01Date precision: month
Registry last updated2018-01-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
Sponsors & collaborators
Ligand Pharmaceuticalslead sponsor
Mapped research locations
HoustonTexas, United States3ChicagoIllinois, United States1Los AngelesCalifornia, United States1DallasTexas, United States1MiamiFlorida, United States1San DiegoCalifornia, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1OrlandoFlorida, United States1DenverColorado, United States1Las VegasNevada, United States1AlbuquerqueNew Mexico, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02851849 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.